General Archive

Home » Archives for Ella Spittall
  • LifeArc ventures hero graphic
    News releases

    Tribune Therapeutics raises EUR 37 million for next-generation anti-fibrotic therapies

    Tribune Therapeutics AB, a biotechnology company dedicated to treating the root causes of fibrotic diseases, today announced it has raised…

    Read more

  • 3d illustration of a doctor checking a spine on blurred background.
    News releases

    Hillstar Bio closes $67 million Series A financing round

    Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases, today announced the successful…

    Read more

  • 3D illustration of a cell membrane and ion channels
    News releases

    LifeArc invests in Maxion Therapeutics Series A

    Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases,…

    Read more

  • People joining hands together during their meeting
    Blogs

    Reflecting on our commitment to involve patients and the public in our work

    As we join with other partners to celebrate the third anniversary of the Shared Commitment to Public Involvement, it is…

    Read more

  • Panel discussion at the LifeArc Translational Science Summit on MND and Rare Dementias. 3 expert speakers who have MND are on stage with a LifeArc employee chairing the discussion
    Blogs

    Reflections from the LifeArc Translational Science Summit on MND and Rare Dementias

    On 5 March 2025, we hosted a Translational Science Summit on MND and Rare Dementias. From leading researchers, to venture…

    Read more

  • 3D illustration of antibody
    News releases

    LifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs

    LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…

    Read more

  • Headshot of Clare Terlouw
    Articles

    Clare Terlouw, Head of LifeArc Ventures, talks to In Vivo’s Ashley Yeo on the improving investment climate

    “There is a lot of capital out there in biotech land that has been largely locked up. Companies are coming…

    Read more

  • 3D illustration of Microaneurysms where arteries are filled with red blood cells.
    News releases

    LifeArc Ventures invests in Fluid Biomed

    Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular disease, closed an…

    Read more

  • Selfie of Gaynor Hardman on a LifeArc branded background
    Blogs, Patient stories

    Learning to live with a bronchiectasis diagnosis – Gaynor’s story 

    Grandmother of 4, Gaynor Hardman, was diagnosed with bronchiectasis at 61. With limited knowledge and understanding of this condition, she…

    Read more

  • Sam Barrell standing by a railing smiling at the camera in an office building
    News releases

    Dr Sam Barrell CBE joins LifeArc as new CEO 

    We are excited to welcome Dr Sam Barrell, CBE, as she officially joins the LifeArc team today as our new…

    Read more

  • Catriona Crombie featured alongside text with her title and quote
    News releases

    LifeArc funds innovative rare liver disease clinical trial 

    The first patient has been recruited for the FARGO clinical trial, funded by LifeArc and PSC Support, which explores a…

    Read more

  • Two female scientists in lab coats and gloves work at a lab bench.
    Articles

    Bronchiectasis: an overlooked lung condition with untapped commercial and research potential

    Bronchiectasis (BE) is a chronic lung condition that significantly impacts the lives of many people in the UK and around…

    Read more